Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 42708-004

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 42708-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (42708 003 30)

Label for Atorvastatin Calcium Tablets, 10 mg, containing 30 tablets. The label indicates the product is distributed by QPharma, Inc., Cedar Knolls, NJ. It includes storage instructions to keep the container tightly closed at controlled room temperature and to keep out of reach of children. Dosage fields are blank for customization. The label also states this is a sample not for sale and is prescription only (Rx Only).*

FDA Label Image

Label (42708 004 30)

Atorvastatin Calcium Tablets, 20 mg film-coated oral tablets, with a package containing 30 tablets. The label indicates the product is distributed by QPharma, Inc., Cedar Knolls, NJ. It includes instructions space for dosage, storage at controlled room temperature, and standard cautions such as keeping the container tightly closed and out of reach of children. The label is marked as a sample and Rx Only.*

FDA Label Image

Label (42708 005 30)

Packaging label for Atorvastatin Calcium Tablets, 40 mg, containing 30 film-coated tablets. The label includes instructions to see the package insert for dosage and storage at controlled room temperature. Distributed by QPharma, Inc., Cedar Knolls, NJ. The label states the product is Rx Only and includes placeholders for dosage instructions and expiration details.*

FDA Label Image

Chemical Structure (Image 1)

Chemical structure diagram of Atorvastatin Calcium including its molecular components and hydration state, represented with structural formula and calcium ion notation.*

FDA Label Image

Figure 1 (Image 2)

A line graph showing cumulative incidence (%) over a 3.5-year period comparing Atorvastatin and placebo. The graph features two lines: a solid line for Atorvastatin and a dashed line for placebo, with Atorvastatin demonstrating consistently lower cumulative incidence. The hazard ratio (HR) of 0.64 (95% CI 0.50 to 0.83) with a p-value of 0.0005 is noted on the chart.*

FDA Label Image

Figure 2 (Image 3)

A line graph depicting cumulative hazard percentage over time to first primary endpoint through four years of follow-up, comparing Atorvastatin versus placebo. The x-axis represents years from 0 to 5, and the y-axis shows cumulative hazard from 0% to 15%. Two lines display hazard values: a solid line for Atorvastatin and a dashed line for placebo. The graph includes a hazard ratio (HR) of 0.63 with confidence interval 0.48 to 0.83 and a p-value of 0.001.*

FDA Label Image

Figure 3 (Image 4)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time for Atorvastatin 10 mg versus Atorvastatin 80 mg. The x-axis shows time in years to the first major cardiovascular endpoint, and the y-axis shows the percentage of subjects. The graph includes hazard ratio and p-value data indicating statistical analysis of the event rates between the two dosages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.